4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-053433
Chairman and CEO bought 185,000 shares at an average $0.11 ($20,370)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-09-26 | Purchase | +6,000 | $0.20 | $1,200 | 11,339,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-09-27 | Purchase | +5,000 | $0.20 | $1,000 | 11,344,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-03 | Purchase | +10,000 | $0.20 | $2,000 | 11,354,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-04 | Purchase | +5,000 | $0.16 | $800 | 11,359,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-05 | Purchase | +10,000 | $0.15 | $1,500 | 11,369,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-06 | Purchase | +5,000 | $0.15 | $750 | 11,374,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-07 | Purchase | +4,000 | $0.13 | $520 | 11,378,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-10 | Purchase | +10,000 | $0.09 | $900 | 11,388,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-11 | Purchase | +130,000 | $0.09 | $11,700 | 11,518,857 | D |
| Open-market purchases · 185,000 sh · avg $0.11 · $20,370 | |||||||
Loading xslF345X03/doc4.xml…